Identification of Functional Differences in Metabolic Networks Using Comparative Genomics and Constraint-Based Models
暂无分享,去创建一个
[1] R. Mahadevan,et al. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.
[2] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[3] Vinay Satish Kumar,et al. Metabolic reconstruction of the archaeon methanogen Methanosarcina Acetivorans , 2011, BMC Systems Biology.
[4] Jonathan A. Kelner,et al. Large-scale identification of genetic design strategies using local search , 2009, Molecular systems biology.
[5] B. Palsson,et al. Systems approach to refining genome annotation , 2006, Proceedings of the National Academy of Sciences.
[6] Adam M. Feist,et al. Model-driven evaluation of the production potential for growth-coupled products of Escherichia coli. , 2010, Metabolic engineering.
[7] Peter D. Karp,et al. The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases , 2007, Nucleic Acids Res..
[8] B. Palsson,et al. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) , 2003, Genome Biology.
[9] N. Murata,et al. Acyl-lipid desaturases and their importance in the tolerance and acclimatization to cold of cyanobacteria. , 1995, The Biochemical journal.
[10] Bernhard O. Palsson,et al. BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions , 2010, BMC Bioinformatics.
[11] Peter D. Karp,et al. Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology , 2015, Briefings Bioinform..
[12] Adam M. Feist,et al. Reconstruction of biochemical networks in microorganisms , 2009, Nature Reviews Microbiology.
[13] K. Reynolds,et al. Purification, Characterization, and Identification of Novel Inhibitors of the β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.
[14] P. Fu,et al. Genome‐scale modeling of Synechocystis sp. PCC 6803 and prediction of pathway insertion , 2009 .
[15] A. Melis,et al. Engineering a platform for photosynthetic isoprene production in cyanobacteria, using Synechocystis as the model organism. , 2010, Metabolic engineering.
[16] B. Palsson,et al. Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.
[17] Naryttza N. Diaz,et al. The Subsystems Approach to Genome Annotation and its Use in the Project to Annotate 1000 Genomes , 2005, Nucleic acids research.
[18] Tomer Shlomi,et al. Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways , 2010, Bioinform..
[19] R. Hancock. Mechanisms of action of newer antibiotics for Gram-positive pathogens. , 2005, The Lancet. Infectious diseases.
[20] Xuefeng Lu,et al. Photosynthesis driven conversion of carbon dioxide to fatty alcohols and hydrocarbons in cyanobacteria. , 2011, Metabolic engineering.
[21] Kathleen Marchal,et al. A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2 , 2011, BMC Systems Biology.
[22] Jason A. Papin,et al. Reconciliation of Genome-Scale Metabolic Reconstructions for Comparative Systems Analysis , 2011, PLoS Comput. Biol..
[23] Michael C. Ferris,et al. Linear programming with MATLAB , 2007, MPS-SIAM series on optimization.
[24] A. Burgard,et al. Minimal Reaction Sets for Escherichia coli Metabolism under Different Growth Requirements and Uptake Environments , 2001, Biotechnology progress.
[25] Jens Nielsen,et al. Evolutionary programming as a platform for in silico metabolic engineering , 2005, BMC Bioinformatics.
[26] H. Neu,et al. The Crisis in Antibiotic Resistance , 1992, Science.
[27] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[28] K. Gajiwala,et al. Structure-based design, synthesis, and study of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents , 2005 .
[29] John A Morgan,et al. Flux Balance Analysis of Photoautotrophic Metabolism , 2005, Biotechnology progress.
[30] Ying Zhang,et al. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. , 2003, The Journal of antimicrobial chemotherapy.
[31] Bernhard O. Palsson,et al. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .
[32] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[33] R. Skurray,et al. Antimicrobial resistance of Staphylococcus aureus: genetic basis. , 1987, Microbiological reviews.
[34] A. Burgard,et al. Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization , 2003, Biotechnology and bioengineering.
[35] C. Aldrich,et al. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine. , 2008, Journal of medicinal chemistry.
[36] David L. Wheeler,et al. GenBank , 2015, Nucleic Acids Res..
[37] Priyanka Verma,et al. Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis , 2009, Nature chemical biology.
[38] William R. Jacobs,et al. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis , 2000, Nature Medicine.
[39] Kiran Raosaheb Patil,et al. Reconstruction and analysis of genome-scale metabolic model of a photosynthetic bacterium , 2010, BMC Systems Biology.
[40] D. Bumann. Has nature already identified all useful antibacterial targets? , 2008, Current opinion in microbiology.
[41] Jennifer L. Reed,et al. OptORF: Optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains , 2010, BMC Systems Biology.
[42] B. Palsson,et al. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation , 2005, BMC Microbiology.
[43] Christoph Benning,et al. BIOSYNTHESIS AND FUNCTION OF THE SULFOLIPID SULFOQUINOVOSYL DIACYLGLYCEROL. , 1998, Annual review of plant physiology and plant molecular biology.
[44] James C Liao,et al. Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde , 2009, Nature Biotechnology.
[45] G. Stephanopoulos,et al. Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. , 2005, Metabolic engineering.
[46] C. Stoeckert,et al. OrthoMCL: identification of ortholog groups for eukaryotic genomes. , 2003, Genome research.
[47] V. Hatzimanikatis,et al. Manipulating redox and ATP balancing for improved production of succinate in E. coli. , 2011, Metabolic engineering.
[48] J. Reed,et al. Large-Scale Bi-Level Strain Design Approaches and Mixed-Integer Programming Solution Techniques , 2011, PloS one.
[49] Rick L. Stevens,et al. High-throughput generation, optimization and analysis of genome-scale metabolic models , 2010, Nature Biotechnology.
[50] Costas D Maranas,et al. OptStrain: a computational framework for redesign of microbial production systems. , 2004, Genome research.
[51] Markus J. Herrgård,et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology , 2008, Nature Biotechnology.
[52] Jason A. Papin,et al. Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.
[53] Markus J. Herrgård,et al. Integrating high-throughput and computational data elucidates bacterial networks , 2004, Nature.
[54] F. Blattner,et al. In silico design and adaptive evolution of Escherichia coli for production of lactic acid. , 2005, Biotechnology and bioengineering.
[55] William R Cluett,et al. EMILiO: a fast algorithm for genome-scale strain design. , 2011, Metabolic engineering.
[56] S. Lee,et al. Metabolic Engineering of Escherichia coli for Enhanced Production of Succinic Acid, Based on Genome Comparison and In Silico Gene Knockout Simulation , 2005, Applied and Environmental Microbiology.
[57] S. Lee,et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery , 2011, Molecular systems biology.
[58] Jim K. Fredrickson,et al. Constraint-Based Model of Shewanella oneidensis MR-1 Metabolism: A Tool for Data Analysis and Hypothesis Generation , 2010, PLoS Comput. Biol..
[59] Xinyao Liu,et al. Fatty acid production in genetically modified cyanobacteria , 2011, Proceedings of the National Academy of Sciences.
[60] John D. C. Little,et al. On model building , 1993 .
[61] R. Lange,et al. The targets of currently used antibacterial agents: lessons for drug discovery. , 2007, Current pharmaceutical design.
[62] V. Stepanshina,et al. [Molecular mechanisms of drug resistance of Mycobacterium tuberculosis]. , 1999, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].
[63] Bernhard O. Palsson,et al. Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction , 2009, BMC Systems Biology.
[64] C. Walsh,et al. D-Alanyl-D-alanine ligases and the molecular mechanism of vancomycin resistance , 1992 .
[65] Costas D. Maranas,et al. OptForce: An Optimization Procedure for Identifying All Genetic Manipulations Leading to Targeted Overproductions , 2010, PLoS Comput. Biol..
[66] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[67] A. Sauve,et al. Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism. , 2010, Biochemistry.
[68] W. Lockau,et al. The Metabolic Network of Synechocystis sp. PCC 6803: Systemic Properties of Autotrophic Growth1[C][W] , 2010, Plant Physiology.
[69] Jim K. Fredrickson,et al. Genome-Scale Modeling of Light-Driven Reductant Partitioning and Carbon Fluxes in Diazotrophic Unicellular Cyanobacterium Cyanothece sp. ATCC 51142 , 2012, PLoS Comput. Biol..
[70] Adam M. Feist,et al. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.
[71] L. Nielsen,et al. The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli , 2011, BMC Genomics.
[72] C. Walsh. Opinion — anti-infectives: Where will new antibiotics come from? , 2003, Nature Reviews Microbiology.
[73] C. Maranas,et al. An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. , 2006, Metabolic engineering.
[74] Jun Sun,et al. Genome-scale constraint-based modeling of Geobacter metallireducens , 2009, BMC Systems Biology.
[75] H. P. Williams,et al. Model Building in Mathematical Programming , 1979 .
[76] Adam M. Feist,et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.
[77] Jun Sun,et al. Constraint-based modeling analysis of the metabolism of two Pelobacter species , 2010, BMC Systems Biology.
[78] D. Bryant,et al. Alteration of low-temperature susceptibility of the cyanobacterium Synechococcus sp. PCC 7002 by genetic manipulation of membrane lipid unsaturation , 1997, Archives of Microbiology.